NO329422B1 - Kondensasjonsderivater av tiocolchicin og baccatin som antitumormidler, farmasoytiske sammensetninger inneholdende dem og anvendelse derav - Google Patents
Kondensasjonsderivater av tiocolchicin og baccatin som antitumormidler, farmasoytiske sammensetninger inneholdende dem og anvendelse derav Download PDFInfo
- Publication number
- NO329422B1 NO329422B1 NO20024353A NO20024353A NO329422B1 NO 329422 B1 NO329422 B1 NO 329422B1 NO 20024353 A NO20024353 A NO 20024353A NO 20024353 A NO20024353 A NO 20024353A NO 329422 B1 NO329422 B1 NO 329422B1
- Authority
- NO
- Norway
- Prior art keywords
- mmol
- formula
- compounds
- thiocolchicine
- baccatin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 4
- 239000002246 antineoplastic agent Substances 0.000 title description 4
- CMEGANPVAXDBPL-INIZCTEOSA-N n-[(7s)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5h-benzo[a]heptalen-7-yl]acetamide Chemical class C1([C@@H](NC(C)=O)CC2)=CC(=O)C(SC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC CMEGANPVAXDBPL-INIZCTEOSA-N 0.000 title description 4
- 229930190007 Baccatin Natural products 0.000 title description 2
- 230000005494 condensation Effects 0.000 title 1
- 238000009833 condensation Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 9
- 230000001028 anti-proliverative effect Effects 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 239000000047 product Substances 0.000 description 17
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 12
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical class C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 8
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- NUNCOHUMTCDISK-AWEZNQCLSA-N (7s)-7-amino-1,2,3-trimethoxy-10-methylsulfanyl-6,7-dihydro-5h-benzo[a]heptalen-9-one Chemical compound C1([C@@H](N)CC2)=CC(=O)C(SC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC NUNCOHUMTCDISK-AWEZNQCLSA-N 0.000 description 6
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical group NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- 102000029749 Microtubule Human genes 0.000 description 4
- 108091022875 Microtubule Proteins 0.000 description 4
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 4
- 210000004688 microtubule Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- -1 N-trifluoroacetylamino acids Chemical class 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229930012538 Paclitaxel Natural products 0.000 description 3
- 102000004243 Tubulin Human genes 0.000 description 3
- 108090000704 Tubulin Proteins 0.000 description 3
- 229960001338 colchicine Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229960001592 paclitaxel Drugs 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical class O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 description 1
- 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
- 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 description 1
- 206010059024 Gastrointestinal toxicity Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000002634 anti-blastic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004200 baccatin III derivatives Chemical class 0.000 description 1
- 125000003834 baccatin III group Chemical group 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 229960005052 demecolcine Drugs 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 231100000414 gastrointestinal toxicity Toxicity 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 150000002917 oxazolidines Chemical class 0.000 description 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 1
- GNWXVOQHLPBSSR-UHFFFAOYSA-N oxolane;toluene Chemical compound C1CCOC1.CC1=CC=CC=C1 GNWXVOQHLPBSSR-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI000553A IT1319168B1 (it) | 2000-03-17 | 2000-03-17 | Derivati di condensazione ad attivita' antitumorale, loro metodo dipreparazione e formulazioni che li contengono. |
| PCT/EP2001/002740 WO2001068089A1 (en) | 2000-03-17 | 2001-03-12 | Condensation derivatives of thiocolchicine and baccatin as antitumor agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20024353L NO20024353L (no) | 2002-09-12 |
| NO20024353D0 NO20024353D0 (no) | 2002-09-12 |
| NO329422B1 true NO329422B1 (no) | 2010-10-18 |
Family
ID=11444500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024353A NO329422B1 (no) | 2000-03-17 | 2002-09-12 | Kondensasjonsderivater av tiocolchicin og baccatin som antitumormidler, farmasoytiske sammensetninger inneholdende dem og anvendelse derav |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6683109B2 (ja) |
| EP (1) | EP1263431B1 (ja) |
| JP (1) | JP2003526665A (ja) |
| KR (1) | KR100766161B1 (ja) |
| CN (1) | CN1204886C (ja) |
| AU (2) | AU5037701A (ja) |
| CA (1) | CA2403168C (ja) |
| CZ (1) | CZ301626B6 (ja) |
| DK (1) | DK1263431T3 (ja) |
| ES (1) | ES2305067T3 (ja) |
| HK (1) | HK1051973A1 (ja) |
| HU (1) | HU229257B1 (ja) |
| IL (1) | IL151714A0 (ja) |
| IT (1) | IT1319168B1 (ja) |
| NO (1) | NO329422B1 (ja) |
| PL (1) | PL357376A1 (ja) |
| PT (1) | PT1263431E (ja) |
| RU (1) | RU2264393C2 (ja) |
| SI (1) | SI1263431T1 (ja) |
| SK (1) | SK286849B6 (ja) |
| WO (1) | WO2001068089A1 (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6649632B2 (en) | 2000-02-02 | 2003-11-18 | Fsu Research Foundation, Inc. | C10 ester substituted taxanes |
| CO5280224A1 (es) | 2000-02-02 | 2003-05-30 | Univ Florida State Res Found | Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen |
| CA2354471A1 (en) * | 2001-07-31 | 2003-01-31 | Florida State University Research Foundation, Inc. | C10 ester substituted taxanes |
| US6825236B2 (en) * | 2003-04-14 | 2004-11-30 | California Pacific Medical Center | Colchicine derivatives |
| SV2006002010A (es) | 2004-02-13 | 2006-08-23 | Univ Florida State Res Found | Taxanos sustituidos con esteres de ciclopentilo en c10 |
| WO2005087222A1 (en) | 2004-03-05 | 2005-09-22 | Florida State University Research Foundation, Inc. | C7 lactyloxy-substituted taxanes |
| EP2276755A4 (en) | 2008-03-31 | 2011-05-04 | Univ Florida State Res Found | C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2678930B1 (fr) * | 1991-07-10 | 1995-01-13 | Rhone Poulenc Rorer Sa | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii. |
| AU2400692A (en) * | 1991-07-19 | 1993-02-23 | Hybritech Incorporated | Trifunctional compounds having specificity for multi-drug resistant cells |
| CA2124329C (en) * | 1991-11-27 | 2008-11-18 | Gregory A. Kopia | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| US5426224A (en) * | 1993-03-18 | 1995-06-20 | The University Of North Carolina At Chapel Hill | Mammalian DNA topoisomerase II inhibitor and method |
| WO1997024459A1 (en) * | 1995-12-29 | 1997-07-10 | Phanos Technologoes, Inc. | Method for reducing unwanted cellular adhesions |
| PT1114815E (pt) * | 1996-05-08 | 2005-01-31 | Upjohn Co | Processo para a preparacao de taxol |
-
2000
- 2000-03-17 IT IT2000MI000553A patent/IT1319168B1/it active
-
2001
- 2001-03-12 DK DK01923660T patent/DK1263431T3/da active
- 2001-03-12 CZ CZ20023084A patent/CZ301626B6/cs not_active IP Right Cessation
- 2001-03-12 CN CNB018064434A patent/CN1204886C/zh not_active Expired - Fee Related
- 2001-03-12 CA CA2403168A patent/CA2403168C/en not_active Expired - Fee Related
- 2001-03-12 SK SK1311-2002A patent/SK286849B6/sk not_active IP Right Cessation
- 2001-03-12 EP EP01923660A patent/EP1263431B1/en not_active Expired - Lifetime
- 2001-03-12 WO PCT/EP2001/002740 patent/WO2001068089A1/en active IP Right Grant
- 2001-03-12 AU AU5037701A patent/AU5037701A/xx active Pending
- 2001-03-12 HU HU0300198A patent/HU229257B1/hu not_active IP Right Cessation
- 2001-03-12 IL IL15171401A patent/IL151714A0/xx not_active IP Right Cessation
- 2001-03-12 RU RU2002124523/04A patent/RU2264393C2/ru not_active IP Right Cessation
- 2001-03-12 PL PL01357376A patent/PL357376A1/xx not_active Application Discontinuation
- 2001-03-12 KR KR1020027011946A patent/KR100766161B1/ko not_active IP Right Cessation
- 2001-03-12 SI SI200130838T patent/SI1263431T1/sl unknown
- 2001-03-12 JP JP2001566653A patent/JP2003526665A/ja active Pending
- 2001-03-12 PT PT01923660T patent/PT1263431E/pt unknown
- 2001-03-12 ES ES01923660T patent/ES2305067T3/es not_active Expired - Lifetime
- 2001-03-12 AU AU2001250377A patent/AU2001250377B2/en not_active Ceased
-
2002
- 2002-08-02 US US10/210,134 patent/US6683109B2/en not_active Expired - Fee Related
- 2002-09-12 NO NO20024353A patent/NO329422B1/no not_active IP Right Cessation
-
2003
- 2003-06-16 HK HK03104269A patent/HK1051973A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100514809B1 (ko) | 신규 택산 유도체 | |
| KR100255524B1 (ko) | 탁산 유도체, 그의 제조방법 및 종양에 있어서의 용도 | |
| CN114591201A (zh) | 具有HDACi药效团的β-榄香烯衍生物及其制备方法和应用 | |
| NO329422B1 (no) | Kondensasjonsderivater av tiocolchicin og baccatin som antitumormidler, farmasoytiske sammensetninger inneholdende dem og anvendelse derav | |
| JP2018536619A (ja) | トリプトリドのｃ１４ヒドロキシルエステル化アミノ酸誘導体、ならびにその製造方法および使用 | |
| Sagar et al. | Bisubstrate analogue structure–activity relationships for p300 histone acetyltransferase inhibitors | |
| RU2257379C2 (ru) | Производные n-деацетилтиоколхицина и содержащие их фармацевтические композиции | |
| AU2001250377A1 (en) | Condensation derivatives of thiocolchicine and baccatin as antitumor agents | |
| AU2001248341A1 (en) | N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them | |
| CZ20001869A3 (cs) | Meziprodukt pro výrobu paclitaxelu | |
| CN105985401B (zh) | 一种雷公藤红素衍生物、其制备方法及用途 | |
| CN111454274B (zh) | 倍半萜内酯—saha衍生物的制备方法及其在制备抗癌药物中的用途 | |
| Wang et al. | The preparation of novel L-iso-glutamine derivatives as potential antitumor agents | |
| CN1318408C (zh) | 一种含氮杂环β－榄香烯酰胺类衍生物其制备及应用 | |
| JP6453706B2 (ja) | 新規なグルタミン酸誘導体およびその用途 | |
| Miyasaka et al. | Synthesis of novel streptonigrin 2-amide derivatives with 3, 3′-(phenylphosphoryl) bis (1, 3-thiazolidine-2-thione) | |
| CN1318405C (zh) | 一种含氮杂环β－榄香烯哌嗪烷基类衍生物其制备及应用 | |
| CN1318407C (zh) | 一种用于合成含氮杂环β－榄香烯衍生物的中间体化合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |